▷ Forbion European Acquisition Corp. Announces $ 110 Million Pricing …

11.12.2021 – 01:42

Forbion European Acquisition Corp.

Naarden, the Netherlands, Feb. 23 / PRNewswire /

Forbion European Acquisition Corp. (the “Company”) today announced pricing for its initial public offering of 11,000,000 units at a price of $ 10.00 per unit. Shares are expected to be listed on the Nasdaq Global Market under the ticker “FRBNU” on December 10, 2021 “admitted to trading. Each unit consists of one Class A common share of the Company and one-third of a redeemable warrant, with each entire warrant exercisable to purchase one Class A common share at a price of $ 11.50 per share. Once the securities making up the Units are traded separately, the Company expects that its Class A common stock and warrants will be listed on the Nasdaq Global Market under the symbols “FRBN” and “FRBNW”, respectively.

The company was formed for the purpose of a merger, share swap, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or entities. The company’s efforts to identify a potential business combination opportunity are not limited to any particular industry or geographic region.

UBS Investment Bank and Kempen & Co act as joint book running managers. The company has given the lead managers a 45-day option to purchase up to 1,650,000 additional units at the initial issue price to cover any over-allotments.

The public offer is made exclusively on the basis of a sales prospectus. When available, copies of the prospectus for the offering can be obtained from UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by calling (888) 827-7275 or emailing [email protected] or Kempen & Co. USA, Inc., Attention: John McGowan, by phone at 1-212-37600132 or by email at [email protected]

A registration notice relating to these securities was made effective by the US Securities and Exchange Commission (“SEC”) on December 9, 2021. This press release constitutes neither an offer to sell nor an invitation to buy any securities, nor may these securities be included in any of the securities State or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. The offer is expected to close on December 14, 2021 , subject to customary closing conditions.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements” relating, among other things, to the company’s proposed public offering and the company’s plans with respect to the target industry for a potential business combination. No assurance can be given that the offer described above will meet the conditions described or that the company will ultimately conduct a business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the company, including those set out in the Risk Factors section of the registration statement and preliminary prospectus for the company’s offering filings with the US Securities and Exchange Commission (the “SEC”). Copies of these documents are available on the SEC’s website at www.sec.gov accessible. The company undertakes no obligation to update these statements with revisions or changes after the date of this announcement, except as required by law.

Press contact:

Media Relations,
Laura Asbjornsen,
Head of Communications,
[email protected]; Investor Relations,
Jasper Bos,
Chief Executive Officer,
Forbion European Acquisition Corp.,
[email protected]

Original content by: Forbion European Acquisition Corp., transmitted by news aktuell


Leave a Reply

Your email address will not be published.